Andrew J. Schwab, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 23/08/28

Trade details

Type: Insider sale
Amount: $5,873,984
Shares · price: 367,124 sh · $16.00 a share
Held after: 4,470,968 sh
Stock: Enliven Therapeutics ELVN
Person: Andrew J. Schwab10% Owner
Trade date: 23/08/24
Filed: 23/08/28
Days to filing: 4 days

Sold 7.6% of holdings

Share of holding sold: 7.6%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/25~23/09/23

Andrew J. Schwab's recent trades

Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$184.9K
114,851 sh
$184.9K
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$45.6K
27,612 sh
$45.6K
Filed 09/24
Traded 09/22
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$7,290
4,528 sh
$7,290
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$1,795
1,088 sh
$1,795
Filed 09/24
Traded 09/22
Andrew J. Schwab10% Owner
SellEntrada Therapeutics
Sell
Entrada Therapeutics
TRDA
$1.8M
200,000 sh
$1.8M
Filed 25/11/18
Traded 25/11/14

Andrew J. Schwab, 10% Owner — sold $5.9M of Enliven Therapeutics ELVN · 7.6% of holdings | Whalegun